Allergy relieving Eye Drops Market

Allergy relieving Eye Drops Market (Drug Class - Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors; Type - Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis; Distribution Channel - Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Allergy-relieving Eye Drops Market - Snapshot

The global allergy-relieving eye drops market is expected to reach a value of US$ 1,930.3 Mn by the end of 2026, expanding at a significant CAGR of 5.0% during the forecast period. Increase in prevalence and incidence rates of eye-related disorders, high unmet needs in patients with ocular allergy, increased geriatric population, raised awareness about eye diseases in developing countries are expected to boost the allergy-relieving eye drops market during the forecast period. Moreover, significant rise in incidence of eye-related diseases, especially in developed countries, is anticipated to drive the allergy-relieving eye drops market between 2018 and 2026. According to the Prevent Blindness Report, the number of people in the U.S. suffering from cataract is expected to increase from 24.4 Mn in 2010, to 30.5 Mn by 2020, and the number of people suffering from diabetic retinopathy in the U.S. is projected to rise from 7.7 Mn in 2010 to reach 9.2 Mn by 2020

The global allergy-relieving eye drops market has been segmented based on drug class, type, distribution channel, and region. In terms of drug class, the global market has been classified into antihistamines, non-steroidal anti-inflammatory drugs, vasoconstrictors, and others. The antihistamines segment dominates the allergy-relieving eye drops market, in terms of value. The wide acceptance of antihistamines as the first line of treatment for allergic conjunctivitis is likely to drive the segment. Furthermore, increase in the prevalence of allergic conjunctivitis and rise in awareness about eye-related disorders are anticipated to propel the segment during the forecast period. This segment is also expected to expand at a significant CAGR, owing to its effectiveness in the treatment of ocular allergy. The vasoconstrictors segment follows the antihistamines segment, in terms of share, of the global allergy-relieving eye drops market. The dominance of the segment is attributed to the extensive utilization of vasoconstrictors to relieve redness of the eyes associated with ocular allergy.

allergy-relieving-eye-drops-market.jpg

In terms of type, the global market has been classified into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis, and others. The seasonal and perennial allergic conjunctivitis segment is likely to dominate the global allergy-relieving eye drops market during the forecast period.

In terms of distribution channel, the allergy-relieving eye drops market has been segregated into hospital pharmacies, retail, and online sales. The retail segment held a major share of the market in 2017, followed by hospital pharmacies. The retail segment is expected to maintain its market share during forecast period due to the availability of both prescription as well as OTC drugs for allergic conjunctivitis. The online pharmacies segment is projected to expand at a considerable CAGR during the forecast period, owing to easy availability of drugs at home at a discounted price and long-term treatment required for certain form of ocular allergies.

In terms of region, the allergy-relieving eye drops market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the allergy-relieving eye drops market, owing to the high awareness about minor eye-related disorders in the U.S. and increased prevalence of allergic conjunctivitis in the region. Moreover, North America is anticipated to be a highly attractive market for allergy-relieving eye drops during the forecast period, owing to the high cost of prescription drugs and a significant number of people in this region covered by medical insurance.

Major players operating in the allergy-relieving eye drops market include Allergan Plc., Johnson & Johnson Services, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd. Key players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase the product availability and thereby boost the market.

Rising Prevalence of Eye Infections Worldwide to Propel Growth of Allergy Relieving Eye Drops Market

Increasing prevalence and occurrence paces of eye-related issues, high neglected requirements in patients with visual allergy, expanded geriatric populace, brought issues to light about eye sicknesses in agricultural nations are relied upon to support the allergy-relieving eye drops market during the conjecture time frame. Also, critical ascent in rate of eye-related sicknesses, particularly in created nations, is expected to drive the allergy-relieving eye drops market.

The wide acknowledgment of antihistamines as the main line of treatment for hypersensitive conjunctivitis is probably going to drive the antihistamines section of this market. Moreover, expansion in the pervasiveness of hypersensitive conjunctivitis and ascend in mindfulness about eye-related problems are expected to impel the portion during the gauge time frame. This fragment is likewise expected to grow at a huge CAGR, attributable to its adequacy in the treatment of visual allergy. The vasoconstrictors section follows the antihistamines fragment, as far as offer, of the worldwide allergy-relieving eye drops market. The predominance of the fragment is credited to the broad usage of vasoconstrictors to alleviate redness of the eyes related with visual allergy.

The rapidly expanding geriatric populace is inclined to huge danger of eye-related issues, including visual deficiency. Public mindfulness with respect to regular eye conditions is expanding in non-industrial nations, prompting early analysis and treatment of eye illnesses. Besides, countless associations are committed to battle visual impairment, reestablish vision, and make mindfulness with respect to eye wellbeing. Critical ascent in frequency of eye-related infections, particularly in created nations, is expected to drive this market.

Geographically, North America rules the allergy-relieving eye drops market, attributable to the high mindfulness about minor eye-related issues in the U.S. furthermore, expanded predominance of unfavorably susceptible conjunctivitis around there. Besides, North America is expected to be a profoundly alluring business sector for allergy-free eye drops during the gauge time frame, inferable from the significant expense of physician endorsed drugs and a critical number of individuals in this district covered by clinical protection.

The global allergy-relieving eye drops market has been segmented as below:

Drug Class

  • Antihistamines
  • Non-steroidal anti-Inflammatory Drugs
  • Vasoconstrictors
  • Others

Type

  • Seasonal and Perennial Allergic Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis
  • Giant Papillary Conjunctivitis
  • Others

Distribution Channel

 

  • Hospital Pharmacies
  • Retail
  • Online Sales

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Allergy-relieving Eye Drops Market

    4. Market Overview
         4.1. Introduction
                4.1.1. Market Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
         4.4. Global Allergy-relieving Eye Drops Market Analysis and Forecast, 2016–2026
                4.4.1. Market Revenue Projections (US$ Mn)
         4.5. Porter’s Five Force Analysis

    5. Market Outlook
         5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
         5.2. Pipeline Analysis
         5.3. Regulatory Scenario by Region

    6. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Drug Class
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                6.3.1. Antihistamines
                6.3.2. Non-steroidal Anti-inflammatory Drugs
                6.3.3. Vasoconstrictors
                6.3.4. Others
         6.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class

    7. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Type
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                7.3.1. Seasonal and Perennial Allergic Conjunctivitis
                7.3.2. Vernal Keratoconjunctivitis
                7.3.3. Atopic Keratoconjunctivitis
                7.3.4. Giant Papillary Conjunctivitis
                7.3.5. Others
         7.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Type

    8. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Distribution Channel
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                8.3.1. Hospital Pharmacies
                8.3.2. Retail
                8.3.3. Online Sales
         8.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel

    9. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Region
         9.1. Key Findings
         9.2. Global Allergy-relieving Eye Drops Market Value Forecast, by Region
                9.2.1. North America
                9.2.2. Europe
                9.2.3. Asia Pacific
                9.2.4. Latin America
                9.2.5. Middle East & Africa
         9.3. Global Allergy-relieving Eye Drops Market Attractiveness, by Country/Region

    10. North America Allergy-relieving Eye Drops Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
         10.2. North America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                10.2.1. Antihistamines
                10.2.2. Non-steroidal Anti-inflammatory Drugs
                10.2.3. Vasoconstrictors
                10.2.4. Others
         10.3. North America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                10.3.1. Seasonal and Perennial Allergic Conjunctivitis
                10.3.2. Vernal Keratoconjunctivitis
                10.3.3. Atopic Keratoconjunctivitis
                10.3.4. Giant Papillary Conjunctivitis
                10.3.5. Others
         10.4. North America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                10.4.1. Hospital Pharmacies
                10.4.2. Retail
                10.4.3. Online Sales
         10.5. North America Allergy-relieving Eye Drops Market Value Forecast, by Country, 2016–2026
                10.5.1. US
                10.5.2. Canada
         10.6. North America Allergy-relieving Eye Drops Market Attractiveness Analysis
                10.6.1. By Drug Class
                10.6.2. By Type
                10.6.3. By Distribution Channel
                10.6.4. By Country

    11. Europe Allergy-relieving Eye Drops Market Analysis and Forecast
         11.1. Introduction
                11.1.1. Key Findings
         11.2. Europe Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                11.2.1. Antihistamines
                11.2.2. Non-steroidal Anti-inflammatory Drugs
                11.2.3. Vasoconstrictors
                11.2.4. Others
         11.3. Europe Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                11.3.1. Seasonal and Perennial Allergic Conjunctivitis
                11.3.2. Vernal Keratoconjunctivitis
                11.3.3. Atopic Keratoconjunctivitis
                11.3.4. Giant Papillary Conjunctivitis
                11.3.5. Others
         11.4. Europe Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                11.4.1. Hospital Pharmacies
                11.4.2. Retail
                11.4.3. Online Sales
         11.5. Europe Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
                11.5.1. Germany
                11.5.2. France
                11.5.3. U.K.
                11.5.4. Italy
                11.5.5. Spain
                11.5.6. Rest of Europe
         11.6. Europe Allergy-relieving Eye Drops Market Attractiveness Analysis
                11.6.1. By Drug Class
                11.6.2. By Type
                11.6.3. By Distribution Channel
                11.6.4. By Country/Sub-region

    12. Asia Pacific Allergy-relieving Eye Drops Market Analysis and Forecast
         12.1. Introduction
                12.1.1. Key Findings
         12.2. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                12.2.1. Antihistamines
                12.2.2. Non-steroidal Anti-inflammatory Drugs
                12.2.3. Vasoconstrictors
                12.2.4. Others
         12.3. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                12.3.1. Seasonal and Perennial Allergic Conjunctivitis
                12.3.2. Vernal Keratoconjunctivitis
                12.3.3. Atopic Keratoconjunctivitis
                12.3.4. Giant Papillary Conjunctivitis
                12.3.5. Others
         12.4. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                12.4.1. Hospital Pharmacies
                12.4.2. Retail
                12.4.3. Online Sales
         12.5. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
                12.5.1. Japan
                12.5.2. China
                12.5.3. India
                12.5.4. Australia & New Zealand
                12.5.5. Rest of Asia Pacific
         12.6. Asia Pacific Allergy-relieving Eye Drops Market Attractiveness Analysis
                12.6.1. By Drug Class
                12.6.2. By Type
                12.6.3. By Distribution Channel
                12.6.4. By Country/Sub-region

    13. Latin America Allergy-relieving Eye Drops Market Analysis and Forecast
         13.1. Introduction
                13.1.1. Key Findings
         13.2. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                13.2.1. Antihistamines
                13.2.2. Non-steroidal Anti-inflammatory Drugs
                13.2.3. Vasoconstrictors
                13.2.4. Others
         13.3. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                13.3.1. Seasonal and Perennial Allergic Conjunctivitis
                13.3.2. Vernal Keratoconjunctivitis
                13.3.3. Atopic Keratoconjunctivitis
                13.3.4. Giant Papillary Conjunctivitis
                13.3.5. Others
         13.4. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                13.4.1. Hospital Pharmacies
                13.4.2. Retail
                13.4.3. Online Sales
         13.5. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
                13.5.1. Brazil
                13.5.2. Mexico
                13.5.3. Rest of Latin America
         13.6. Latin America Allergy-relieving Eye Drops Market Attractiveness Analysis
                13.6.1. By Drug Class
                13.6.2. By Type
                13.6.3. By Distribution Channel
                13.6.4. By Country/Sub-region

    14. Middle East & Africa Allergy-relieving Eye Drops Market Analysis and Forecast
         14.1. Introduction
                14.1.1. Key Findings
         14.2. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
                14.2.1. Antihistamines
                14.2.2. Non-steroidal Anti-inflammatory Drugs
                14.2.3. Vasoconstrictors
                14.2.4. Others
         14.3. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
                14.3.1. Seasonal and Perennial Allergic Conjunctivitis
                14.3.2. Vernal Keratoconjunctivitis
                14.3.3. Atopic Keratoconjunctivitis
                14.3.4. Giant Papillary Conjunctivitis
                14.3.5. Others
         14.4. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
                14.4.1. Hospital Pharmacies
                14.4.2. Retail
                14.4.3. Online Sales
         14.5. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region 2016–2026
                14.5.1. GCC Countries
                14.5.2. Israel
                14.5.3. South Africa
                14.5.4. Rest of MEA
         14.6. Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness Analysis
                14.6.1. By Drug Class
                14.6.2. By Type
                14.6.3. By Distribution Channel
                14.6.4. By Country/Sub-region

    15. Competition Landscape
         15.1. Global Allergy-relieving Eye Drops Market Share Analysis, by Company (2016)
         15.2. Company Profiles
                15.2.1. Allergan plc.
                         15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.1.2. Product Portfolio
                         15.2.1.3. SWOT Analysis
                         15.2.1.4. Financial Overview
                         15.2.1.5. Strategic Overview
                15.2.2. Novartis AG
                         15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.2.2. Product Portfolio
                         15.2.2.3. SWOT Analysis
                         15.2.2.4. Financial Overview
                         15.2.2.5. Strategic Overview
                15.2.3. Johnson & Johnson Services, Inc.
                         15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.3.2. Product Portfolio
                         15.2.3.3. SWOT Analysis
                         15.2.3.4. Financial Overview
                         15.2.3.5. Strategic Overview
                15.2.4. Pfizer, Inc.
                         15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.4.2. Product Portfolio
                         15.2.4.3. SWOT Analysis
                         15.2.4.4. Financial Overview
                         15.2.4.5. Strategic Overview
                15.2.5. F. Hoffmann-La Roche Ltd.
                         15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.5.2. Product Portfolio
                         15.2.5.3. SWOT Analysis
                         15.2.5.4. Financial Overview
                         15.2.5.5. Strategic Overview
                15.2.6. Bausch Health Companies Inc.
                         15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.6.2. Product Portfolio
                         15.2.6.3. SWOT Analysis
                         15.2.6.4. Financial Overview
                         15.2.6.5. Strategic Overview
                15.2.7. Regeneron Pharmaceuticals, Inc.
                         15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.7.2. Product Portfolio
                         15.2.7.3. SWOT Analysis
                         15.2.7.4. Financial Overview
                         15.2.7.5. Strategic Overview
                15.2.8. Santen Pharmaceutical Co., Ltd.
                         15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.2.8.2. Product Portfolio
                         15.2.8.3. SWOT Analysis
                         15.2.8.4. Financial Overview
                         15.2.8.5. Strategic Overview

    List of Tables

    Table 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 02: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 03: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
    Table 04: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 05: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 06: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 07: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 08: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
    Table 09: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
    Table 10: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 11: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 12: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
    Table 13: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 14: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 15: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 16: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
    Table 17: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 18: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 19: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 20: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
    Table 21: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 22: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
    Table 23: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 24: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

    List of Figures

    Figure 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
    Figure 02: Global Allergy-relieving Eye Drops Market Revenue, by Drug Class, 2018(E) 
    Figure 04: Global Allergy-relieving Eye Drops Market Revenue Share
    Figure 05: Global Allergy-relieving Eye Drops Market Revenue Share
    Figure 06: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 07: Global Allergy-relieving Eye Drops Market Value Share, by Type (2017)
    Figure 08: Global Allergy-relieving Eye Drops Market Value Share, by Distribution Channel (2017)
    Figure 09: Global Allergy-relieving Eye Drops Market Value Share, by Region (2017)
    Figure 10: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Drug Class, 2018 and 2026
    Figure 11: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antihistamines, 2016–2026
    Figure 12: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Non-steroidal Anti-inflammatory Drugs, 2016–2026
    Figure 13: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vasoconstrictors, 2016–2026
    Figure 14: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
    Figure 15: Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 16: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 17: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Seasonal and Perennial Allergic Conjunctivitis, 2016–2026
    Figure 18: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vernal Keratoconjunctivitis, 2016–2026
    Figure 19: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atopic Keratoconjunctivitis, 2016–2026
    Figure 20: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Giant Papillary Conjunctivitis, 2016–2026
    Figure 21: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
    Figure 22: Global Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 23: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Distribution Channel, 2018 and 2026
    Figure 24: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
    Figure 25: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail, 2016–2026
    Figure 26: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Sales, 2016–2026
    Figure 27: Global Allergy-relieving Eye Drops Market Attractiveness Analysis, by Distribution Channel
    Figure 28: Global Allergy-relieving Eye Drops Market Value Share (%), by Region, 2018 and 2026
    Figure 29: Global Allergy-relieving Eye Drops Market Attractiveness, by Region, 2018–2026
    Figure 30: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 31: North America Allergy-relieving Eye Drops Market Attractiveness, by Country, 2018–2026
    Figure 32: North America Allergy-relieving Eye Drops Market Value Share, by Country, 2017 and 2026
    Figure 33: North America Allergy-relieving Eye Drops Market Value Share, by  Drug Class, 2017 and 2026
    Figure 34: North America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 35: North America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 36: North America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 37: North America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
    Figure 38: North America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
    Figure 39: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 40: Europe Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
    Figure 41: Europe Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
    Figure 42: Europe Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
    Figure 43: Europe Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 44: Europe Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 45: Europe Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 46: Europe Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
    Figure 47: Europe Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
    Figure 48: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 49: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 50: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 51: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by  Drug Class, 2017 and 2026
    Figure 52: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 53: Asia Pacific Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 54: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 55: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
    Figure 56: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
    Figure 57: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 58: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 59: Latin America Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 60: Latin America Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
    Figure 61: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 62: Latin America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 63: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 64: Latin America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
    Figure 65: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
    Figure 66: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 67: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
    Figure 68: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
    Figure 69: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
    Figure 70: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
    Figure 71: Middle East & Africa Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
    Figure 72: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
    Figure 73: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
    Figure 74: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
    Figure 75: Allergan plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
    Figure 76: Allergen plc. R&D Expenses (USD Mn), 2016–2017
    Figure 77: Allergan plc. Sales and Marketing Expenses (USD Mn), 2017
    Figure 78: Allergan plc. Breakdown of Net Sales, by Business Segment, 2017
    Figure 79 : Johnson & Johnson Services, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
    Figure 80: Johnson & Johnson Services, Inc. Vision care revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2017
    Figure 81: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
    Figure 82: Johnson & Johnson Services, Inc.(Research & Development Cost, 2015 – 2017 (US$ Bn)
    Figure 83: Pfizer, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
    Figure 84: Pfizer, Inc. R&D Expenses and SI&A Expenses (%) 2015–2017
    Figure 85: Pfizer, Inc. Breakdown of Net Sales, by Geography (Essential Health Segment), 2017
    Figure 86: Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2017
    Figure 87: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Business Segment, 2017
    Figure 88: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
    Figure 89: F. Hoffmann-La Roche Ltd. Research & Development Cost, 2015 – 2017 (US$ Bn)
    Figure 90: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 91: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 92: Novartis AG Breakdown of Net Sales, by Region, 2017
    Figure 93: Novartis AG Breakdown of Net Sales, by Business Segments, 2017
    Figure 94: Bausch Health Companies Inc. Breakdown of Net Sales (%), by Region, 2017
    Figure 95: Bausch Health Companies Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
    Figure 96: Bausch Health Companies Inc. Breakdown of Revenues(%), by Product Category, 2017
    Figure 97: Bausch Health Companies Inc. R&D Expenses (US$ Mn), 2015-2017
    Figure 98: Regeneron Pharmaceuticals, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
    Figure 99: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn), 2013-2017
    Figure 100: Santen Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 101: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Operating Segments, 2017
    Figure 102: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Region, 2017
    Figure 103: Santen Pharmaceutical Co., Ltd. Research & Development Cost, 2015–2017 (US$ Mn)

Copyright © Transparency Market Research, Inc. All Rights reserved